
Metpride M 2mg/500mg Tablet SR
Marketer
Assure Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Metpride M 2mg/500mg Tablet SR
DiabetaComb 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are vital. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Metpride M 2mg/500mg Tablet SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Metpride M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metpride M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metpride M 2mg/500mg Tablet SR whole; do not crush, chew, or fracture it. Administer this medication with food.
Common Side effects of Metpride M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metpride M 2mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metpride M 2mg/500mg Sustained-Release tablets with a meal.
How Metpride M 2mg/500mg Tablet SR works:
Metpride M SR tablets (2mg/500mg) combine glimepiride and metformin, two agents used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metpride M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metpride M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingUNSAFE
Extended-release Metpride M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Metpride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Metpride M 2mg/500mg SR tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metpride M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Metpride M 2mg/500mg Tablet SR should typically begin at a low dose; however, it's unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Metpride M 2mg/500mg Tablet SR :
Should you forget to take a Metpride M 2mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Metpride M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
